Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark.
Eworuke E, Shinde MU, Hou L, Paterson JM, Jensen PB, Maro JC, Rai A, Pottegård A, Scarnecchia D, Liang Y, Johnson D, Platt RW, Lee H, Bradley MC.
Eworuke E, et al. Among authors: pottegard a.
Pharmacoepidemiol Drug Saf. 2024 Sep;33(9):e5849. doi: 10.1002/pds.5849.
Pharmacoepidemiol Drug Saf. 2024.
PMID: 39289955